-5%
Exelon Transdermal Patch 5cm belongs to a class of medications known as “anti-dementia agents” and is utilized to address mild to moderate dementia stemming from Alzheimer’s or Parkinson’s disease. Alzheimer’s disease is a neurological condition characterized by dementia, leading to memory loss and a gradual decline in cognitive abilities. Parkinson’s disease, on the other hand, is a central nervous system disorder impacting movement, resulting in symptoms such as tremors, stiffness, and challenges in walking and coordination.
- Exelon Transdermal Patch 5cm contains Rivastigmine, classified as a cholinesterase inhibitor.
- It is prescribed for the treatment of mild to moderately severe Alzheimer’s dementia and dementia associated with Parkinson’s disease.
- Used to address progressive brain disorders affecting memory, intellectual abilities, and behavior.
- Belongs to the cholinesterase inhibitors group.
- Addresses low levels of acetylcholine, a neurotransmitter crucial for communication between nerve cells.
- Administered according to doctor’s instructions.
- The dose is influenced by factors such as age, concurrent medications, and kidney or liver conditions.
- Not recommended for pregnant women and breastfeeding mothers.